Multiple Manufacturers

DRONABINOL

Manufacturer:

Multiple Manufacturers

Dronabinol HCPCS:

Q0167

HCPCS Code Descriptor:

Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Category:

Q Code

Dronabinol NDCs:

53097-0570-60, 53097-0569-60, 53097-0571-60, 53097-0568-60, 00904-7144-61, 67877-0755-60, 67877-0570-60, 00904-7145-04, 67877-0754-60, 67877-0569-60, 67877-0753-60, 67877-0568-60

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

53097-0570-60, 53097-0569-60, 53097-0568-60, 00904-7144-61, 67877-0570-60, 67877-0569-60, 67877-0568-60

About Dronabinol:

DRONABINOL is an Oncology-Anti-Emetic drug manufactured by Ascend Laboratories and administered via the Oral route of administration. The Q Code: Q0167 is aligned to the drug DRONABINOL.

ACCESS PRICING AND MORE BY REGISTERING

Q0167 Added Date:

April 1, 1998

Q0167 Effective Date:

April 1, 1998

Q0167 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Dronabinol billing and coding information.
Our team did not identify a source for Dronabinol patient assistance information. Please reach out to our team if you feel that this is a mistake.
DRONABINOL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for DRONABINOL. Please check back in a few weeks.